1-4 of 4
Ferdinand Rossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V-Mutant Gastrointestinal Stromal Tumor

Ferdinand Rossi, Mengyuan Liu, Andrew Tieniber, Mark S. Etherington, Andrew Hanna, Gerardo A. Vitiello, Nesteene J. Param, Kevin Do, Laura Wang, Cristina R. Antonescu, Shan Zeng, Jennifer Q. Zhang, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2144–2157.
https://doi.org/10.1158/1078-0432.CCR-22-0533
Published: 01 June 2023
View article titled, Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in <em>PDGFRA D842V</em>-Mutant Gastrointestinal Stromal Tumor
Open the PDF for Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in <em>PDGFRA D842V</em>-Mutant Gastrointestinal Stromal Tumor in another window
Includes: Supplementary data
Journal Articles

Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

Gerardo A. Vitiello, Benjamin D. Medina, Shan Zeng, Timothy G. Bowler, Jennifer Q. Zhang, Jennifer K. Loo, Nesteene J. Param, Mengyuan Liu, Alec J. Moral, Julia N. Zhao, Ferdinand Rossi, Cristina R. Antonescu, Vinod P. Balachandran, Justin R. Cross, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 972–984.
https://doi.org/10.1158/1078-0432.CCR-17-2697
Published: 14 February 2018
View article titled, Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor
Open the PDF for Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor in another window
Includes: Supplementary data
Journal Articles

PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors

Adrian M. Seifert, Shan Zeng, Jennifer Q. Zhang, Teresa S. Kim, Noah A. Cohen, Michael J. Beckman, Benjamin D. Medina, Joanna H. Maltbaek, Jennifer K. Loo, Megan H. Crawley, Ferdinand Rossi, Peter Besmer, Cristina R. Antonescu, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 454–465.
https://doi.org/10.1158/1078-0432.CCR-16-1163
Published: 15 January 2017
View article titled, PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
Open the PDF for PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data
Journal Articles

Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor

Teresa S. Kim, Michael J. Cavnar, Noah A. Cohen, Eric C. Sorenson, Jonathan B. Greer, Adrian M. Seifert, Megan H. Crawley, Benjamin L. Green, Rachel Popow, Nagavarakishore Pillarsetty, Darren R. Veach, Anson T. Ku, Ferdinand Rossi, Peter Besmer, Cristina R. Antonescu, Shan Zeng, Ronald P. DeMatteo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (9): 2350–2362.
https://doi.org/10.1158/1078-0432.CCR-13-3033
Published: 30 April 2014
View article titled, Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
Open the PDF for Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor in another window
Includes: Supplementary data